The first demonstration of conjugal plasmid transfer from Escherichia coli to Bartonella henselae is reported. Transconjugants bearing plasmids of incompatibility groups P (IncP) and Q (IncQ), expressing various resistance markers, were generated. Tn5 transposons delivered on suicide plasmids by conjugation showed transpositional insertion into random chromosomal sites.
Bartonella (Rochalimaea) henselae is a newly recognized fastidious gram-negative bacillus (5, 14) that has been associated with a number of human diseases, including bacillary angiomatosis, parenchymal bacillary peliosis, cat scratch disease, and persisting bacteremia (for a review see reference 1). Bacterial virulence determinants involved in the pathogenesis of these manifestations may include factors that stimulate endothelial-cell migration and proliferation in vitro (6) and phasevariable type 4-like pili mediating adherence to and invasion of cultured epithelial cells (2) . The development of tools for the genetic manipulation of B. henselae would aid the study of these and other potential virulence factors. To this end, we have established conjugal plasmid transfer from Escherichia coli to B. henselae and used this process to determine (i) functional origins of replication and antibiotic resistance genes useful for plasmid maintenance and (ii) appropriate transposon delivery systems based on suicide vectors useful for transposon mutagenesis in B. henselae.
The bacterial strains and plasmids used in this study are depicted in Table 1 . E. coli strains were grown at 37ЊC in Luria-Bertani broth supplemented with 1 mM diaminopimelic acid (DAP) and appropriate antibiotics. B. henselae strains were cultivated at 37ЊC and 5% CO 2 on Columbia agar supplemented with 5% defibrinated sheep blood (CSB agar) and appropriate antibiotics. Conditions for conjugal plasmid transfer were established by using E. coli ␤2155(pWB5) as the donor and B. henselae 49882Rif as a recipient. The IncP plasmid derivative pWB5 confers resistances to kanamycin (Km r ) and tetracycline (Tc r ) and is mobilized in trans by transfer functions of plasmid RK4 integrated in the chromosome of ␤2155. Growth of the dapA mutant ␤2155 is strictly dependent on exogenously supplied DAP; hence, the removal of DAP provides an efficient counterselection against this donor. The rifampin resistance (Rif r ) (80 g/ml) of recipient 49882Rif, a spontaneous Rif r mutant of B. henselae ATCC 49882, provides further means for counterselection against the E. coli donor.
Matings were done by mixing phosphate-buffered salinewashed bacteria, corresponding to 0.1 ml of a stationary-phase broth culture of the donor with the bacterial content of a plate of the recipient, which had been grown for 3 days. The mixture, in approximately 0.1 ml of phosphate-buffered saline, was spotted onto a nitrocellulose filter disc (Millipore; 0.22-m pore size), placed on CSB agar containing 1 mM DAP, and incubated for 8 h at 37ЊC and 5% CO 2 . Bacteria were washed from the filter, and dilutions were plated on CSB agar containing 20 g of kanamycin and 50 g of rifampin per ml to select for transconjugants bearing plasmid pWB5. Replicate plates devoid of kanamycin were used to determine the number of CFU of the recipient. Small colonies appeared after 7 to 10 days of incubation at 37ЊC and 5% CO 2 at frequencies of approximately 2 ϫ 10 Ϫ5 transconjugants per recipient. DNA hybridization experiments with total DNA isolated from transconjugants and digested with various restriction enzymes showed the presence of pWB5 without detectable insertions, deletions, or rearrangements ( Fig. 1) .
For conjugal transfer of other IncP and IncQ plasmids, the described mating protocol was modified accordingly. The selfmobilizable IncP plasmid pPH1JI was mobilized from dap mutant ␤2150, an ancestor strain of ␤2155 devoid of the transfer function of plasmid RK4, into B. henselae 49882Rif, and transconjugants were selected on CSB agar containing gentamicin (20 g/ml) and rifampin (50 g/ml). The RK4 transfer functions of ␤2155 were also used to mobilize in trans the IncQ plasmid pSUP106 into B. henselae 49882Rif, and transconjugants were selected on CSB agar containing chloramphenicol (2.5 g/ml) and rifampin (50 g/ml). DNA hybridization experiments of restriction enzyme-digested total DNA isolated from transconjugants showed the presence of pSUP106 without detectable insertions, deletions, or rearrangements (data not shown). pSUP106 contains, in addition to the origin of IncQ plasmid B300, the E. coli origin of p15A. Only the IncQ origin, however, appears to be responsible for plasmid maintenance in B. henselae, as mobilization of the p15A-derived plasmid pSUP101 into B. henselae 49882Rif did not allow the isolation of any transconjugants. Moreover, mobilization of another IncQ plasmid, the RSF1010 derivative pPR39, from ␤2155 into 49882Rif resulted in the isolation of transconju-gants by selection on CSB plates containing gentamicin (10 g/ml) and rifampin (50 g/ml).
Having introduced Km r , Gm r , Tc r , and Cm r determinants into the B. henselae 49882Rif transconjugant, we proceeded to determine the MICs of the corresponding antibiotics. Dilutions of the bacterial strains depicted in Table 2 were plated on CSB agar supplemented with kanamycin or gentamicin at concentrations of 0.1, 0.2, 0.5, 1, 2, 5, 10, 20, 50, 100, and 200 g/ml or with chloramphenicol or tetracycline at concentrations of 0.01, 0.02, 0.05, 0.1, 0.2, 0.4, 0.6, 0.8, 1.0, 1.2, 1.4, 1.6, 1.8, and 2.0 g/ml, and bacterial growth was estimated at 10 and 14 days after plating. The MIC of each antibiotic was defined as the concentration at which there was at least a 1,000-fold reduction in CFU. We observed high MICs of kanamycin (Ͼ200 g/ml) for transconjugant 49882Rif(pWB5) and of gentamicin (50 g/ml) for transconjugant 49882Rif(pPH1JI) compared to the corresponding MICs for the recipient 49882Rif (2 g of kanamycin and 0.2 g of gentamicin per ml). Apparently, Km r and Gm r determinants provide excellent antibiotic resistance markers in B. henselae. The MICs of tetracycline, 1.6 and 0.8 g/ml for transconjugants 49882Rif(pWB5) and 49882Rif (pSUP106), respectively, and of chloramphenicol, 1.6 and 2.8 g/ml for transconjugants 49882Rif(pPH1JI) and 49882Rif (pSUP106), respectively, are significantly higher than the corresponding MICs for the recipient strain 49882Rif (0.2 g of tetracycline and 0.2 g of chloramphenicol per ml), demonstrating that Tc r and Cm r markers are also expressed in B. henselae.
Next we tested whether the established conjugal plasmid FIG. 1. Southern hybridization analysis of DNA from B. henselae 49882Rif (pWB5) (A) and E. coli HB101(pWB5) (B) probed with a fragment of plasmid pWB5. CsCl-purified total DNA (method adapted from reference 10) from B. henselae 49882Rif(pWB5) and plasmid DNA isolated from E. coli HB101 (pWB5) was digested with SalI (lanes 1), HindIII (lanes 2), ClaI (lanes 3), EcoRI (lanes 4), and BamHI (lanes 5). The DNA fragments were separated on a 0.8% agarose gel, transferred to nylon filters (Hybond-N; Amersham) by the Southern procedure (16), and hybridized with a 4.3-kb PstI/SalI fragment of plasmid pWB5, which was radiolabeled with 32 P by a random-prime kit (Amersham). (C) Physical map of plasmid pWB5 and the probe used for hybridization. transfer system based on an E. coli dapA mutant as the donor may also be applicable to other B. henselae isolates. The donor ␤2155(pWB5) was mated with B. henselae ATCC 49882 and ATCC 49793, two isolates from human blood, and strains 58 and 113, both isolated from cat blood, and transconjugants were selected on CSB agar containing kanamycin (20 g/ml).
Transconjugants appeared with a frequency of approximately 1 ϫ 10 Ϫ5 to 6 ϫ 10 Ϫ5 per recipient. Although the plating of high concentrations of the conjugation mixture caused the recovery of some atypically large translucent E. coli colonies on the counterselection medium deprived of DAP, large numbers of B. henselae transconjugants could be recovered in the absence of any contaminating E. coli colony when appropriate dilutions were used. Hence, the use of an E. coli dapA mutant as the donor in conjugal plasmid transfer allowed us to isolate transconjugants for all B. henselae isolates tested.
Classically, transposon mutagenesis has proven to be an extremely useful tool in bacterial genetic research (9) . In order to establish transposon mutagenesis in B. henselae, we delivered Tn5 transposons on suicide vectors by conjugal transfer. B. henselae 49882Rif was conjugated with ␤2155(pSUP2021), and transconjugants were selected on CSB agar containing kanamycin (20 g/ml) and rifampin (30 g/ml). Transconjugants appeared with a frequency of approximately 2 ϫ 10 Ϫ9 per recipient. DNA hybridization experiments with total DNA isolated from independent mutants typically showed the presence of single copies of Tn5 in random chromosomal insertion sites ( Fig. 2A) . Conjugal transfer of the mini-Tn5 transposon containing suicide plasmids pUT/Km, mini-Tn5 Km2, and mini-Tn5 phoA also led to the isolation of transposon insertional mutants, albeit with an approximately twofold reduction in frequency.
In summary, our studies provide the first demonstration of conjugal transfer of plasmid DNA from E. coli to B. henselae. This work has extended the known host range of IncP and IncQ plasmids and of the Tn5 transposon and has established powerful genetic tools applicable to any B. henselae isolate. In particular, Tn5 transposon mutagenesis may aid in the molecular identification and characterization of novel virulence factors of B. henselae, as has been reported for other pathogenic bacteria (11) , and mobilizable broad-host-range plasmids should allow the introduction and in trans expression of any cloned gene in B. henselae.
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